Incyte Corporation
INCY
$86.92
$0.760.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.45% | -10.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.45% | -10.67% | |||
| Cost of Revenue | 13.13% | 20.48% | |||
| Gross Profit | 17.34% | -26.27% | |||
| SG&A Expenses | 1.63% | -0.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.20% | -5.07% | |||
| Operating Income | 43.28% | -27.19% | |||
| Income Before Tax | 138.27% | -25.35% | |||
| Income Tax Expenses | 101.37% | -32.46% | |||
| Earnings from Continuing Operations | 156.00% | -21.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 156.00% | -21.37% | |||
| EBIT | 43.28% | -27.19% | |||
| EBITDA | 39.48% | -26.28% | |||
| EPS Basic | 155.63% | -21.60% | |||
| Normalized Basic EPS | 38.47% | -22.97% | |||
| EPS Diluted | 155.00% | -21.42% | |||
| Normalized Diluted EPS | 38.30% | -23.05% | |||
| Average Basic Shares Outstanding | 0.15% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||